Comerica Bank Regenxbio Inc. Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Regenxbio Inc. stock. As of the latest transaction made, Comerica Bank holds 13,932 shares of RGNX stock, worth $106,161. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,932

Previous 14,328 2.76%

Holding current value

$106,161

Previous $167,000 12.57%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.49 - $14.39 $4,154 - $5,698	-396 Reduced 2.76%	13,932 $146,000
Q2 2024 Aug 15, 2024	SELL	$11.51 - $21.53 $5,363 - $10,032	-466 Reduced 3.15%	14,328 $167,000
Q1 2024 May 15, 2024	SELL	$12.17 - $24.61 $15,285 - $30,910	-1,256 Reduced 7.83%	14,794 $311,000
Q4 2023 Feb 14, 2024	SELL	$12.89 - $20.82 $696 - $1,124	-54 Reduced 0.34%	16,050 $288,000
Q3 2023 Nov 21, 2023	BUY	$16.46 - $19.99 $265,071 - $321,918	16,104 New	16,104 $265,000
Q4 2022 Jan 26, 2023	SELL	$20.4 - $24.73 $132,498 - $160,621	-6,495 Reduced 23.94%	20,633 $0
Q3 2022 Oct 28, 2022	SELL	$22.29 - $35.04 $79,240 - $124,567	-3,555 Reduced 11.59%	27,128 $602,000
Q2 2022 Aug 02, 2022	BUY	$19.35 - $35.04 $3,579 - $6,482	185 Added 0.61%	30,683 $970,000
Q1 2022 Apr 27, 2022	BUY	$24.62 - $34.31 $34,591 - $48,205	1,405 Added 4.83%	30,498 $1.01 Million
Q4 2021 Feb 18, 2022	SELL	$30.19 - $40.28 $96,758 - $129,097	-3,205 Reduced 9.92%	29,093 $951,000
Q3 2021 Nov 22, 2021	BUY	$29.09 - $45.68 $31,184 - $48,968	1,072 Added 3.43%	32,298 $1.35 Million
Q2 2021 Aug 26, 2021	SELL	$32.46 - $40.48 $79,072 - $98,609	-2,436 Reduced 7.24%	31,226 $1.21 Million
Q1 2021 Apr 28, 2021	BUY	$33.61 - $49.95 $114,206 - $169,730	3,398 Added 11.23%	33,662 $1.15 Million
Q4 2020 Jan 28, 2021	SELL	$26.52 - $49.35 $2,545 - $4,737	-96 Reduced 0.32%	30,264 $1.37 Million
Q3 2020 Oct 30, 2020	SELL	$27.01 - $40.26 $55,370 - $82,533	-2,050 Reduced 6.33%	30,360 $835,000
Q2 2020 Jul 31, 2020	BUY	$27.75 - $43.44 $50,643 - $79,278	1,825 Added 5.97%	32,410 $1.19 Million
Q1 2020 May 01, 2020	BUY	$21.5 - $54.2 $24,574 - $61,950	1,143 Added 3.88%	30,585 $990,000
Q4 2019 Feb 07, 2020	BUY	$34.54 - $44.87 $4,041 - $5,249	117 Added 0.4%	29,442 $1.21 Million
Q3 2019 Oct 31, 2019	BUY	$31.84 - $50.88 $15,601 - $24,931	490 Added 1.7%	29,325 $1.04 Million
Q2 2019 Aug 02, 2019	SELL	$42.0 - $59.29 $63,672 - $89,883	-1,516 Reduced 4.99%	28,835 $0
Q1 2019 May 02, 2019	BUY	$40.82 - $62.45 $40,656 - $62,200	996 Added 3.39%	30,351 $0
Q4 2018 Feb 06, 2019	BUY	$39.11 - $75.15 $30,740 - $59,067	786 Added 2.75%	29,355 $1.23 Million
Q3 2018 Nov 01, 2018	BUY	$65.0 - $82.15 $13,910 - $17,580	214 Added 0.75%	28,569 $1.69 Million
Q2 2018 Aug 01, 2018	BUY	$27.2 - $74.35 $771,256 - $2.11 Million	28,355 New	28,355 $2.23 Million

Others Institutions Holding RGNX

# of Institutions

196

Shares Held

43M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account